98 related articles for article (PubMed ID: 11797416)
21. Different effects of valproate on methamphetamine- and cocaine-induced behavioral sensitization in mice.
Li JX; Han R; Deng YP; Chen SQ; Liang JH
Behav Brain Res; 2005 Jun; 161(1):125-32. PubMed ID: 15904719
[TBL] [Abstract][Full Text] [Related]
22. MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research.
Clemens KJ; McGregor IS; Hunt GE; Cornish JL
Drug Alcohol Rev; 2007 Jan; 26(1):9-15. PubMed ID: 17364831
[TBL] [Abstract][Full Text] [Related]
23. Behavioral sensitization to the discriminative stimulus effects of methamphetamine in rats.
Suzuki T; Fukuoka Y; Mori T; Miyatake M; Narita M
Eur J Pharmacol; 2004 Sep; 498(1-3):157-61. PubMed ID: 15363990
[TBL] [Abstract][Full Text] [Related]
24. Valproate and acetyl-L-carnitine prevent methamphetamine-induced behavioral sensitization in mice.
Coccurello R; Caprioli A; Ghirardi O; Virmani A
Ann N Y Acad Sci; 2007 Dec; 1122():260-75. PubMed ID: 18077579
[TBL] [Abstract][Full Text] [Related]
25. [Involvement of prefrontal serotonergic neurons in methamphetamine-induced behavioral sensitization].
Ago Y; Nakamura S; Arikawa S; Yata M; Matsuda T
Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Apr; 28(2):85-91. PubMed ID: 18516987
[TBL] [Abstract][Full Text] [Related]
26. The effects of p-chloroamphetamine, methamphetamine and 3,4-methylenedioxymethamphetamine (ecstasy) on the gene expression of cytoskeletal proteins in the rat brain.
Putzke J; Spina MG; Büchler J; Kovar KA; Wolf G; Smalla KH
Addict Biol; 2007 Mar; 12(1):69-80. PubMed ID: 17407499
[TBL] [Abstract][Full Text] [Related]
27. Social isolation stress significantly enhanced the disruption of prepulse inhibition in mice repeatedly treated with methamphetamine.
Dai H; Okuda H; Iwabuchi K; Sakurai E; Chen Z; Kato M; Iinuma K; Yanai K
Ann N Y Acad Sci; 2004 Oct; 1025():257-66. PubMed ID: 15542725
[TBL] [Abstract][Full Text] [Related]
28. MDMA ('Ecstasy') and methamphetamine combined: order of administration influences hyperthermic and long-term adverse effects in female rats.
Clemens KJ; Cornish JL; Li KM; Hunt GE; McGregor IS
Neuropharmacology; 2005 Aug; 49(2):195-207. PubMed ID: 15993443
[TBL] [Abstract][Full Text] [Related]
29. Drug interaction between methamphetamine and antihistamines: behavioral changes and tissue concentrations of methamphetamine in rats.
Okuda T; Ito Y; Nakagawa N; Hishinuma T; Tsukamoto H; Iwabuchi K; Watanabe T; Kitaichi K; Goto J; Yanai K
Eur J Pharmacol; 2004 Nov; 505(1-3):135-44. PubMed ID: 15556146
[TBL] [Abstract][Full Text] [Related]
30. Differential response of neurotensin to methamphetamine self-administration.
Frankel PS; Hoonakker AJ; Hanson GR
Ann N Y Acad Sci; 2008 Oct; 1139():112-7. PubMed ID: 18991855
[TBL] [Abstract][Full Text] [Related]
31. Blockade of M1 muscarinic acetylcholine receptors modulates the methamphetamine-induced psychomotor stimulant effect.
Lee KW; Tian YH; You IJ; Kwon SH; Ha RR; Lee SY; Kim HC; Jang CG
Neuroscience; 2008 Jun; 153(4):1235-44. PubMed ID: 18455881
[TBL] [Abstract][Full Text] [Related]
32. Reversal of methamphetamine-induced behavioral sensitization by repeated administration of a dopamine D1 receptor agonist.
Shuto T; Kuroiwa M; Hamamura M; Yabuuchi K; Shimazoe T; Watanabe S; Nishi A; Yamamoto T
Neuropharmacology; 2006 Jun; 50(8):991-7. PubMed ID: 16563442
[TBL] [Abstract][Full Text] [Related]
33. Increased plasma concentration and brain penetration of methamphetamine in behaviorally sensitized rats.
Kitaichi K; Morishita Y; Doi Y; Ueyama J; Matsushima M; Zhao YL; Takagi K; Hasegawa T
Eur J Pharmacol; 2003 Mar; 464(1):39-48. PubMed ID: 12600693
[TBL] [Abstract][Full Text] [Related]
34. Differential response of nNOS knockout mice to MDMA ("ecstasy")- and methamphetamine-induced psychomotor sensitization and neurotoxicity.
Itzhak Y; Anderson KL; Ali SF
Ann N Y Acad Sci; 2004 Oct; 1025():119-28. PubMed ID: 15542708
[TBL] [Abstract][Full Text] [Related]
35. The altered disposition of methamphetamine in the model of methamphetamine-induced neurotoxicity.
Kitaichi K; Ito Y; Fukuda M; Aoyama N; Nakayama H; Takagi K; Hasegawa T
Ann N Y Acad Sci; 2004 Oct; 1025():248-56. PubMed ID: 15542724
[TBL] [Abstract][Full Text] [Related]
36. Approaches to the development of medications for the treatment of methamphetamine dependence.
Vocci FJ; Appel NM
Addiction; 2007 Apr; 102 Suppl 1():96-106. PubMed ID: 17493058
[TBL] [Abstract][Full Text] [Related]
37. [Alterations in brain distribution of methamphetamine in methamphetamine-sensitized animals].
Mizugaki M
Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Oct; 16(5):187-91. PubMed ID: 8962438
[TBL] [Abstract][Full Text] [Related]
38. Sex differences in methamphetamine pharmacokinetics in adult rats and its transfer to pups through the placental membrane and breast milk.
Rambousek L; Kacer P; Syslova K; Bumba J; Bubenikova-Valesova V; Slamberova R
Drug Alcohol Depend; 2014 Jun; 139():138-44. PubMed ID: 24726427
[TBL] [Abstract][Full Text] [Related]
39. Transient drug-primed but persistent cue-induced reinstatement of extinguished methamphetamine-seeking behavior in mice.
Yan Y; Yamada K; Nitta A; Nabeshima T
Behav Brain Res; 2007 Feb; 177(2):261-8. PubMed ID: 17182116
[TBL] [Abstract][Full Text] [Related]
40. Melatonin attenuates methamphetamine-induced reduction of tyrosine hydroxylase, synaptophysin and growth-associated protein-43 levels in the neonatal rat brain.
Kaewsuk S; Sae-ung K; Phansuwan-Pujito P; Govitrapong P
Neurochem Int; 2009 Nov; 55(6):397-405. PubMed ID: 19409439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]